SMARCA4 and non-small cell lung carcinoma: Previous studies have uncovered several synthetic lethal interactions of SMARCA4 loss in NSCLC cells, including suppression of SMARCA28,9, a non-catalytic activity of EZH210, and aurora kinase A11.